SEP 14, 2020 2:46 PM PDT

MiR-107 and Its Role in Radiosensitivity in Prostate Cancer

WRITTEN BY: Jasper Cantrell

It is often unknown whether a patient will respond to a treatment until it is in full swing. New research is attempting to identify chemo and radiosensitivity mechanisms in cancers and how to use them to reverse resistances.

An area of keen interest is microRNAs and their role in cancer. MicroRNAs (miRNAs) are small snippets of RNA that regulate many processes in the cell. During the development of cancer, their levels fluctuate and can become inactive or overactive. This new study wanted to focus on one miRNA in particular, miR-107, and its effect on prostate cancer’s radiosensitivity.

Previous studies had already shown that miR-107 becomes downregulated after radiation therapy. A link between miR-107 and a pro-cancer growth factor called granulin had previously been identified, but not in the context of radiation therapy. The team hypothesized that both miR-107 and granulin might play a role in the radiosensitivity of prostate cancer.

They first confirmed that miR-107 was downregulated after radiotherapy by following its prostate cancer cell line levels before and after radiation. Artificially upregulating miR-107 impaired prostate cancer cells’ growth after radiation, inferring miR-107 has tumor suppressor activities.

Next, the team looked at granulin levels in the same settings. A previous study and several prediction tools showed the miR-107 should target and regulate granulin expression. Granulin was also upregulated in prostate cancer cells after radiation, in contrast to the downregulation in miR-107. When miR-107 was artificially upregulated, granulin levels went down in response, which effectively showed miR-107 likely regulated granulin in prostate cancer cells. The anti-cancer effects seen in miR-107 upregulation were also found to be due to its regulation of granulin, as knockdown of granulin caused the same results.

This study successfully revealed miR-107 as a player in the radio-sensitivity of prostate cancer cells through its regulation of granulin. Granulin has been linked to cancer progression in several previous studies and is upregulated after prostate cancer radiation. Artificial upregulation of miR-107 suppresses granulin levels and impairs cancer growth. One could imagine a miR-107 upregulating therapy alongside radiotherapy for maximum effectiveness.

The study concludes, “Collectively, these data suggest an unrecognized mechanism of miR-107/ GRN regulation in response to ionizing radiation, which provide a potential therapeutic strategy for improving radiosensitivity of prostate cancer.”

Sources: Nature Scientific Reports, Memorial Sloan Kettering

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
JAN 31, 2021
Genetics & Genomics
Targeting Aneuploidy in Cancer Cells
JAN 31, 2021
Targeting Aneuploidy in Cancer Cells
Cancer is typically related to problems in cells' genomes that lead to uncontrolled cell growth, and the formation of tu ...
MAR 11, 2021
Cell & Molecular Biology
Deadly Cancer Cells Can Move in the Wrong Direction
MAR 11, 2021
Deadly Cancer Cells Can Move in the Wrong Direction
Cancer is most deadly when it metastasizes; when cells break away from a primary site of cancer and move through the bod ...
MAR 19, 2021
Cancer
What does RNA editing do to the immune system?
MAR 19, 2021
What does RNA editing do to the immune system?
A recent study published in the journal Nature Communications from the University of Colorado Cancer Center explores new ...
MAR 30, 2021
Immunology
Single-Cell Technology Exposes Melanoma's Weak Spot
MAR 30, 2021
Single-Cell Technology Exposes Melanoma's Weak Spot
The immune system encompasses a powerful arsenal of weapons against pathogenic threats. But what stops healthy tissues i ...
APR 12, 2021
Cancer
Using antibodies to treat melanoma
APR 12, 2021
Using antibodies to treat melanoma
New research presented at the American Association of Cancer Research (AACR) virtual annual meeting this week from the Y ...
MAY 08, 2021
Cancer
More evidence supports the evils of sugary drinks
MAY 08, 2021
More evidence supports the evils of sugary drinks
New research published online in the journal Gut from researchers at the Washington University School of Medicine i ...
Loading Comments...